Profile
MDWD VRTX REGN SGEN ALNY ARGX
Company Name MediWound Ltd. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $208.16M $116.96B $55.30B $43.15B $41.50B $33.66B
Employees 0.11K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Ofer Gonen Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
Trading
MDWD VRTX REGN SGEN ALNY ARGX
Last Close $19.26 $441.3 $521 $228.74 $322.83 $560.14
High 52 $22.24 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 $14.51 $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High -13.4 % -14.6 % -56.65 % 0 % -0.67 % -16.61 %
Price vs. 52 Week Low 32.74 % 11.26 % 7.89 % 0 % 43.75 % 30.25 %
Total Return
MDWD VRTX REGN SGEN ALNY ARGX
1 Month Return -12.3 % -0.17 % 6.27 % 0 % 6.02 % -2.29 %
3 Month Return 20.75 % -10.43 % -18.26 % 0 % 20.25 % -4.92 %
6 Month Return 7.54 % 10.5 % -25.85 % 0 % 36.79 % -9.65 %
9 Month Return 6.64 % -5.11 % -50.44 % 0 % 17.38 % 3.33 %
YTD Return 8.2 % 9.59 % -26.86 % 0 % 37.19 % -8.92 %
1 Year Return 24.1 % -5.85 % -50.43 % 0 % 32.85 % 30.25 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MDWD VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.34 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -2.08 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
MDWD VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 13.03 % 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -41.12 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -113.56 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -41.32 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100.2 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 155.48 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM -95.94 % -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -199.89 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM 3.46 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 4.29 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM 6.53 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM 97.24 % 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM 27.51 % 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.21 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.79 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 84.84 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -64.38 % -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 148.18 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -199.89 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -10.79 -92.97 18.31 -81.26 -550.45 -433.65
Price To Operating Cash Flows Ratio TTM -15.96 -119.36 14.06 -93.1 -914.84 -515.25
Price Cash Flow Ratio TTM -15.96 -119.36 14.06 -93.1 -914.84 -515.25
Income Statement (TTM)
MDWD VRTX REGN SGEN ALNY ARGX
Revenue $0.02B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 13.03% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.03B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.03B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -3.03 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
MDWD VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.01B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.04B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.03B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0.01B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.07B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
MDWD VRTX REGN SGEN ALNY ARGX
Net Income $-0.03B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0.01B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.22
AARD Aardvark Therapeutics, Inc. Common Stock 13.5
ABCL AbCellera Biologics Inc. 3.42
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.69
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.165
ABPWW 0.0207
ABSI Absci Corporation 2.57
ABUS Arbutus Biopharma Corporation 3.08
ABVC ABVC BioPharma, Inc. 2.225
ABVX Abivax SA American Depositary Shares 7.665
ACAD ACADIA Pharmaceuticals Inc. 21.58
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6143
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.25
ACIU AC Immune SA 2.02
ETFs With Exposure to MDWD
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00661 215.905
IWO iShares Russell 2000 Growth ETF 0.01409 285.86
HDG ProShares Hedge Replication ETF 0.000936065 49.63
UWM ProShares Ultra Russell2000 0.00554321 37.74
VTHR Vanguard Russell 3000 Index Fund 0 272.92
IWC iShares Micro-Cap ETF 0.04572 127.885
IZRL ARK Israel Innovative Technology ETF 1.64 27.17
URTY ProShares UltraPro Russell2000 0.00443706 39.43
VTWG Vanguard Russell 2000 Growth Index Fund 0.02 208.775
VTWO Vanguard Russell 2000 Index Fund 0.01 87.29
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF 0.45 30.95
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0.01 41.33
AIIQ AI Powered International Equity ETF 0.48 24.58
QQQS Invesco NASDAQ Future Gen 200 ETF 0.409 26.77
RSSL Global X Funds 0.01 85.065
Unlock